Heterozygous gain-of-function (GoF) mutations in PIEZO2 have been reported in MWKS, DA3, DA5, which typically involve congenital contractures of hands and feet, or cleft palate, ophthalmoplegia, ptosis, and cerebellar malformations [8, 22–24]. Here, PIEZO2 is linked to ptosis.